Intervention Review

Combination chemotherapy for primary treatment of high-risk gestational trophoblastic tumour

  1. Linyu Deng1,
  2. Jing Zhang2,
  3. Taixiang Wu3,*,
  4. Theresa A Lawrie4

Editorial Group: Cochrane Gynaecological Cancer Group

Published Online: 31 JAN 2013

Assessed as up-to-date: 14 NOV 2012

DOI: 10.1002/14651858.CD005196.pub4


How to Cite

Deng L, Zhang J, Wu T, Lawrie TA. Combination chemotherapy for primary treatment of high-risk gestational trophoblastic tumour. Cochrane Database of Systematic Reviews 2013, Issue 1. Art. No.: CD005196. DOI: 10.1002/14651858.CD005196.pub4.

Author Information

  1. 1

    West China Hospital, Sichuan University, National Key Laboratory of Biotherapy and Cancer Centre, Chengdu, Sichuan, China

  2. 2

    West China Second University Hospital, Sichuan University, Department of Obstetrics and Gynecology, Chengdu, Sichuan, China

  3. 3

    West China Hospital, Sichuan University, Chinese Clinical Trial Registry, Chinese Ethics Committee of Registering Clinical Trials, Chengdu, Sichuan, China

  4. 4

    Royal United Hospital, Cochrane Gynaecological Cancer Group, Bath, UK

*Taixiang Wu, Chinese Clinical Trial Registry, Chinese Ethics Committee of Registering Clinical Trials, West China Hospital, Sichuan University, No. 37, Guo Xue Xiang, Chengdu, Sichuan, 610041, China. txwutx@hotmail.com.

Publication History

  1. Publication Status: Edited (no change to conclusions)
  2. Published Online: 31 JAN 2013

SEARCH

Cited in:

CrossRef

This article has been cited by:

  1. 1
    F. Taylor, T. Grew, J. Everard, L. Ellis, M.C. Winter, J. Tidy, B.W. Hancock, R.E. Coleman, The outcome of patients with low risk gestational trophoblastic neoplasia treated with single agent intramuscular methotrexate and oral folinic acid, European Journal of Cancer, 2013, 49, 15, 3184

    CrossRef